Toker lab identifies metabolic vulnerability in TNBC
Ludwig researchers have shown that triple-negative breast cancer cells ramp up production of a key component of DNA in response to chemotherapy and that targeting this pathway could undermine their resistance to such therapies. Coverge from Ludwig Cancer...